These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6273776)

  • 21. Immunoglobulin GM and KM allotypes and antibody responses to Epstein-Barr virus antigens.
    Pandey JP
    J Infect Dis; 2009 Sep; 200(5):834. PubMed ID: 19653832
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus.
    Svedmyr A; Demissie A; Klein G; Clifford P
    J Natl Cancer Inst; 1970 Mar; 44(3):595-610. PubMed ID: 11515428
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antibodies against non-structural antigens of Epstein-Barr virus in children with infectious mononucleosis].
    Najberg G
    Med Dosw Mikrobiol; 1983; 35(1):55-9. PubMed ID: 6314071
    [No Abstract]   [Full Text] [Related]  

  • 24. [Analysis of viral capsid anti-antigen antibodies of the Epstein Barr virus in infectious mononucleosis. Comparative evaluation of a fluorescence method with classic methods].
    Picerno G; Lari M; Fregoso F; Musmanno G
    Quad Sclavo Diagn; 1983 Dec; 19(4):489-98. PubMed ID: 6330785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfer of cell migration inhibition in vitro with xenogeneic RNA in experimental allergic orchitis.
    Sztein MB; Satz ML; Serrate SA
    J Clin Lab Immunol; 1980 Jan; 3(1):39-43. PubMed ID: 6991705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Construction of the immunoenzyme test system "IFA-AtEBV-Strip" for detecting antibodies of the Epstein-Barr virus].
    Zagorodna SD; Nesterova NV; Diachenko NS; Baranova GV; Rybalko SL; Ivans'ka NV; Vasylenko LG
    Mikrobiol Z; 2001; 63(6):61-70. PubMed ID: 11944337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus, clinical symptomatology and immunodeficiency in non-Hodgkin's lymphoma patients.
    Fejes M; Mochanko K; Brezavscek D; Suárez A; Pavlovsky A; Bachmann AE
    Medicina (B Aires); 1981; 41 Suppl():137-40. PubMed ID: 6285121
    [No Abstract]   [Full Text] [Related]  

  • 28. Conjugation of latent membrane protein (LMP)-2 epitope to gold nanoparticles as highly immunogenic multiple antigenic peptides for induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses in vitro.
    Cheung WH; Chan VS; Pang HW; Wong MK; Guo ZH; Tam PK; Che CM; Lin CL; Yu WY
    Bioconjug Chem; 2009 Jan; 20(1):24-31. PubMed ID: 19102689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elaboration of optical immunosensors based on the surface plasmon resonance for detecting specific antibodies and antigens of Epstein-Barr virus and human adenovirus.
    Nesterova NV; Nosach LM; Zagorodnya SD; Povnitsa OY; Boltovets PM; Baranova GV; Golovan AV
    Mikrobiol Z; 2008; 70(6):67-73. PubMed ID: 19351051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus and rheumatoid arthritis: are rheumatoid arthritis associated nuclear antigen and Epstein-Barr virus nuclear antigen different?
    Cohen JH; Lenoir GM
    Biomed Pharmacother; 1982; 36(5):246-9. PubMed ID: 6301567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
    Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of antigen and fine peptide specificity of EBV-specific CTLs.
    Levitsky V; Frisan T; Masucci M
    Methods Mol Biol; 2001; 174():209-11. PubMed ID: 11357646
    [No Abstract]   [Full Text] [Related]  

  • 33. EGNA-specific LIF production of human lymphocyte subsets.
    Szigeti R; Masucci G; Ehlin-Henriksson B; Bendtzen K; Henle G; Henle W; Klein G; Klein E
    Cell Immunol; 1984 Jan; 83(1):136-41. PubMed ID: 6319032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic evaluation of a new panel of assays for Epstein-Barr virus serology.
    Radtke M; Gärtner B; Franke D
    Clin Lab; 2007; 53(3-4):149-50. PubMed ID: 17447650
    [No Abstract]   [Full Text] [Related]  

  • 35. [Inhibition of leukocyte migration in newborns infants and adults by bovine albumin and PPD].
    Hashimoto-Yáñez B; García-Tamayo F
    Bol Med Hosp Infant Mex; 1983 Jan; 40(1):17-22. PubMed ID: 6338886
    [No Abstract]   [Full Text] [Related]  

  • 36. Leucocyte migration inhibition by tumour-associated antigens in human bladder carcinoma.
    Meleady DF; Butler MR; Greally JF; Mullins GM
    Ir J Med Sci; 1980 Oct; 149(10):391-400. PubMed ID: 7014519
    [No Abstract]   [Full Text] [Related]  

  • 37. Behçet's disease leucocyte inhibitory factor (LIF) in response to skin extract.
    Gilhar A; Haim S; Wolf V; Golan D
    J Dermatol; 1983 Apr; 10(2):185-6. PubMed ID: 6352770
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on leukocyte migration inhibitory factor production by T lymphocytes in viral hepatitis.
    Szkaradkiewicz A; Kiczka W; Adamek J
    Digestion; 1981; 22(3):138-43. PubMed ID: 7026324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of human regulatory myelopeptides on the elaboration of a factor inhibiting leukocyte migration].
    Borisova AM; Glazko AV; Golenkov AK
    Biull Eksp Biol Med; 1988 Jan; 105(1):53-5. PubMed ID: 3276358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Significance of the functional activity of lymphocytes in the pathogenesis of pregnancy nephropathy].
    Gavrilenko AS; Zlatovratskaia TV
    Akush Ginekol (Mosk); 1985 Jun; (6):42-3. PubMed ID: 2932014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.